AI assistant
Sending…
ORAGENICS INC — Director's Dealing 2018
Jul 17, 2018
35380_dirs_2018-07-17_a8dc4c1d-a283-4059-93e9-d27bc8285442.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2018-07-17
Reporting Person: Telling Fred (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-07-17 | Common Stock | P | 100000 | — | Acquired | 239538 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-07-17 | Common Stock Warrants (right to buy) | $1.00 | P | 100000 | Acquired | 2025-07-17 | Common Stock (100000) | Direct |
Footnotes
F1: Purchase of Class A Units consisting of one share of common stock and one warrant to purchase one share of common stock in an underwritten public offering at the price of $1.00 per Unit, which was the price paid by the public for such Units.
More from ORAGENICS INC
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Jan 22
Capital/Financing Update
2026
Jan 22